share_log

绿叶制药(02186.HK)拟8月28日举行董事会会议批准中期业绩

Luye Pharma (02186.HK) is planning to hold a board of directors meeting on August 28 to approve its mid-year performance.

Gelonghui Finance ·  Aug 15 04:49

Luye Pharma (02186.HK) announced on August 15th that the board of directors will hold a meeting on Wednesday, August 28th, 2024 to approve the interim performance of the company and its subsidiaries for the six months ending June 30, 2024, and to consider the distribution of interim dividends (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment